Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Mayne Pharma GroupMAYNF 62 1-Year Share Buyback Ratio is 0.00 as of Jun. 2026. GuruFocus rates MAYNF with a GF Score™ of 62/100 and a GF Value™ of $3.64 (Modestly Undervalued). The stock has 7 warning signs investors should review. Among 51 Medical Distribution companies, Mayne Pharma Group ranks worse than 1960782.35% on this metric.
Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.
1-Year Share Buyback Ratio measures the proportion of a company's outstanding shares repurchased over the past year, calculated as the percentage change in shares outstanding from the previous year to the current year. A positive ratio may indicates share buybacks over the period, while a zero or negative ratio suggests no buybacks or potential share issuance. Mayne Pharma Group's current 1-Year Share Buyback Ratio was 0.00%.
MAYNF's 1-Year Share Buyback Ratio is not ranked *
in the Medical Distribution industry.
Industry Median: -0.3 * Ranked among companies with meaningful 1-Year Share Buyback Ratio only.
Mayne Pharma Group (OTCPK:MAYNF) 1-Year Share Buyback Ratio Explanation
A positive ratio may indicates share buybacks over the period, while a zero or negative ratio suggests no buybacks or potential share issuance.
Be Aware
Investors usually like share buybacks. But as pointed by Warren Buffett, only if a company buys back shares at the prices below the stock's intrinsic value, it rewards remaining shareholders. If a company buys its overvalued stocks back, it destroys shareholder value.
Mayne Pharma Group 1-Year Share Buyback Ratio Related Terms
MAYNF vs MCK, COR, CAH: 1-Year Share Buyback Ratio Comparison
For the Medical Distribution subindustry, Mayne Pharma Group's 1-Year Share Buyback Ratio, along with its competitors' market caps and 1-Year Share Buyback Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Mayne Pharma Group 1-Year Share Buyback Ratio vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Mayne Pharma Group's 1-Year Share Buyback Ratio distribution charts can be found below:
* The bar in red indicates where Mayne Pharma Group's 1-Year Share Buyback Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a 1-Year Share Buyback Ratio of 0.00 mean?
Mayne Pharma Group (MAYNF) has a 1-Year Share Buyback Ratio of 0.00 as of Jun. 2026. The 1-Year Share Buyback Ratio measures the proportion of a company's outstanding shares repurchased over the past year, calculated as the percentage change in shares outstanding from the previous year to the current year. View historical data for Mayne Pharma Group and its competitors. According to the industry distribution chart, Mayne Pharma Group ranks #999999 out of 51 companies in the Medical Distribution industry.
Is Mayne Pharma Group's 1-Year Share Buyback Ratio too high?
Mayne Pharma Group's current 1-Year Share Buyback Ratio is 0.00. Based on the distribution chart, Mayne Pharma Group ranks #999999 out of 51 companies in the Medical Distribution industry, which is in the bottom quartile relative to peers. Overall, Mayne Pharma Group has a GF Score™ of 62/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Mayne Pharma Group's 1-Year Share Buyback Ratio compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Mayne Pharma Group ranks #999999 out of 51 companies for 1-Year Share Buyback Ratio. This places Mayne Pharma Group in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 1-Year Share Buyback Ratio for a Medical Distribution company?
A good 1-Year Share Buyback Ratio depends on the Medical Distribution industry context. However, 1-Year Share Buyback Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 1-Year Share Buyback Ratio mean?
A high 1-Year Share Buyback Ratio can signal that a stock is expensive relative to its fundamentals. The 1-Year Share Buyback Ratio measures the proportion of a company's outstanding shares repurchased over the past year, calculated as the percentage change in shares outstanding from the previous year to the current year. View historical data for Mayne Pharma Group and its competitors. Mayne Pharma Group's current 1-Year Share Buyback Ratio is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mayne Pharma Group stock overvalued right now?
Based on GuruFocus' analysis, Mayne Pharma Group (MAYNF) is currently considered Modestly Undervalued. The stock's GF Value™ is $3.64, compared to a current price of $2.30 — trading 36.8% below its estimated fair value. The current 1-Year Share Buyback Ratio is 0.00. Mayne Pharma Group's overall GF Score™ is 62/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 1-Year Share Buyback Ratio calculated?
1-Year Share Buyback Ratio is calculated from a company's financial statements. For Mayne Pharma Group (MAYNF), the current 1-Year Share Buyback Ratio is 0.00 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Mayne Pharma Group (MAYNF) Overvalued in 2026?
Based on GuruFocus' analysis, Mayne Pharma Group stock appears to be undervalued.
The current stock price of $2.30 is trading 36.8% below its estimated GF Value™ of $3.64.
GuruFocus considers Mayne Pharma Group to be Modestly Undervalued.
Key valuation signals for MAYNF:
1-Year Share Buyback Ratio: 0.00
GF Value™: $3.64 vs. price of $2.30 (36.8% below fair value)
No single metric tells the full story. See the MAYNF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Mayne Pharma Group Ltd is a specialty pharmaceutical company focused on commercializing novel and generic pharmaceuticals It has a Forty-year track record of innovation and success in developing oral drug delivery systems. The Company's Business consists of three operating segments being International, Women's Health and Dermatology. The Dermatologysegment distributes dermatology products (branded and generic) in the U.S. on a portfolio basis, The Women's Health segment distributes branded women's health products in the U.S. International's segment revenue and gross profit are derived principally from the Australian manufacture and sale of branded and generic pharmaceutical products.
62GF Score
Get the complete analysis for MAYNF
1-Year Share Buyback Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MAYNF has been successfully added to your 
